Insights

DISCOVER

COMPANY

Survey

SURVEY

Consulting

COUNSULTING

Create New Account

Book discovery call

Pediatric Vaccines Global Market Report 2020-30: Covid 19 Impact and Recovery

Region:Global

Product Code:7640

Download Sample Report

Published On

April 2020

Total pages

300 Table of Content

Market Overview
Scope Of The Report
Product covered
Table Of Content
Research Methodology
FAQs

Download Sample Report

About the Report

Major players in the pediatric vaccines market are GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Indian Immunologicals Limited, AstraZeneca plc, CSL Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd. and Panacea Biotec Ltd.

The global pediatric vaccines is expected to decline from USD 30.4 billion in 2019 to USD 28.9 billion in 2020 at a compound annual growth rate (CAGR) of -5%. The decline is mainly due to the focus on Covid-19 outbreak and its treatment across the globe and non-availability of vaccines or delay of immunizations in pediatrics. The market will stabilize or grow from next year owing to the easing of supply chain restrictions. Also, successful launch of the covid19 vaccine or immunization of existing BCG vaccine in countries where it is not administered at present, which will boost the pediatric vaccines market significantly in the mid to long term. The market is expected to recover and reach USD 40.7 billion in 2023 at a CAGR of 7.8%.

The pediatric vaccines market consists of sales of pediatric vaccines and its related services used to provide immunity to infants and children for specific diseases. Pediatric vaccine is a preparation of killed microorganisms, living attenuated organisms, or living fully virulent organisms that are administered to stimulate the production of antibodies and provide immunity against one or several diseases among children. Pediatric vaccines are used in childhood immunization schedules to enhance a child's immunity or prevent diseases such as diphtheria, tetanus, pertussis, influenza, Hepatitis B, polio and many other infectious and non-infectious diseases.

The pediatric vaccines market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. North America was the largest region in 2019. Asia Pacific was the fastest region during the period 2019-2025.

The pediatric vaccines market covered in this report is segmented by vaccine type into monovalent, multivalent and by technology into live attenuated, inactivated, toxoid, conjugate, and other technologies.

Vaccine refusal by parents for their children is a prevailing tradition in many countries. Among the reasons for withholding children for vaccination are lack of knowledge, religious and philosophical objections, exaggerated concerns regarding vaccine safety and others. According to a report published by CNBC, the US national refusal rate of parents for a child's immunization was 3.3% in 2018. Governments are imposing laws and organizing awareness programs to overcome parent's and family's resistance to the child's vaccine, but are unable to impose any strict rules against parents' refusal for children's immunization, which is hindering the pediatric vaccines market's growth.

The demand for novel vaccines is steadily growing to deliver improved immunization against challenging infectious diseases (e.g. tuberculosis, HIV/ AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development include structural immunogenic design, gene-based vaccine platforms, and effective adjuvant recombinant antigen formulations. To meet the increasing demand for novel vaccines, there is a continuous quest in pediatric vaccine manufacturers and developers for innovation of vaccine design and manufacturing technologies. For instance, in January 2020, Hilleman laboratories, a global research, and development organization, has announced their plans to develop a novel vaccine against Group B Streptococcus, a major cause for neonatal infections in women, into the area of maternal and child health.

Rising prevalence of chronic diseases such as tuberculosis, diphtheria, and pneumonia in the age group of 15 years and below will contribute to the growth of the pediatric vaccines market. The risk of severe disease outcomes and complications of infectious diseases are increasing in children and adolescents with chronic conditions. As stated by centers for disease control and prevention, the prevalence of obesity was 18.5% in the US and about 13.7 million children and adolescents were affected by obesity in 2015. The increased prevalence of chronic diseases among children rises the demand for immunization from chronic diseases, hence, driving the pediatric vaccines market's growth.

Scope of the Report

Products

1) By Vaccine Type: Monovalent; Multivalent; 2) By Technology: Live Attenuated; Inactivated; Toxoid; Conjugate; Other Technologies

Companies

GlaxoSmithKline plc; Pfizer Inc.; Sanofi S.A.; Merck & Co., Inc.; Indian Immunologicals Limited; AstraZeneca plc; CSL Limited; Mitsubishi Tanabe Pharma Corporation; Serum Institute of India Pvt. Ltd.; Panacea Biotec Ltd.; Zydus Cadila; BIO-MED; Squibb; Novartis; Abbott Laboratries; Eli Lillyand Company; F. Hoffmann- La Roche Ltd.; Novo Nordisk A/S; VF Corporation; Sinovac Biotech Ltd.; Bristol- Myers; Sun Pharmaceutical Industries Ltd; Sellas and Takeda Pharmaceutical Company Limited; Daiichi Sankyo; Bristol- Myers; Sinovac Biotec Ltd.

1. Executive Summary

2. Pediatric Vaccines Market Characteristics

3. Pediatric Vaccines Market Size And Growth

3.1. Global Pediatric Vaccines Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Pediatric Vaccines Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Pediatric Vaccines Market Segmentation

4.1. Global Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Monovalent

Multivalent

4.2. Global Pediatric Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Live Attenuated

Inactivated

Toxoid

Conjugate

Other Technologies

5. Pediatric Vaccines Market Regional And Country Analysis

5.1. Global Pediatric Vaccines Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global Pediatric Vaccines Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific Pediatric Vaccines Market

6.1. Asia-Pacific Pediatric Vaccines Market Overview

6.2. Asia-Pacific Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China Pediatric Vaccines Market

7.1. China Pediatric Vaccines Market Overview

7.2. China Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India Pediatric Vaccines Market

8.1. India Pediatric Vaccines Market Overview

8.2. India Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan Pediatric Vaccines Market

9.1. Japan Pediatric Vaccines Market Overview

9.2. Japan Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia Pediatric Vaccines Market

10.1. Australia Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia Pediatric Vaccines Market

11.1. Indonesia Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea Pediatric Vaccines Market

12.1. South Korea Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe Pediatric Vaccines Market

13.1. Western Europe Pediatric Vaccines Market Overview

13.2. Western Europe Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK Pediatric Vaccines Market

14.1. UK Pediatric Vaccines Market Overview

14.2. UK Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany Pediatric Vaccines Market

15.1. Germany Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France Pediatric Vaccines Market

16.3. France Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe Pediatric Vaccines Market

17.1. Eastern Europe Pediatric Vaccines Market Overview

17.2. Eastern Europe Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia Pediatric Vaccines Market

18.1. Russia Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America Pediatric Vaccines Market

19.1. North America Pediatric Vaccines Market Overview

19.2. North America Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA Pediatric Vaccines Market

20.1. USA Pediatric Vaccines Market Overview

20.2. USA Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America Pediatric Vaccines Market

21.1. South America Pediatric Vaccines Market Overview

21.2. South America Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil Pediatric Vaccines Market

22.1. Brazil Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East Pediatric Vaccines Market

23.1. Middle East Pediatric Vaccines Market Overview

23.2. Middle East Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa Pediatric Vaccines Market

24.1. Africa Pediatric Vaccines Market Overview

24.2. Africa Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. Pediatric Vaccines Market Competitive Landscape And Company Profiles

25.1. Pediatric Vaccines Market Competitive Landscape

25.2. Pediatric Vaccines Market Company Profiles

25.2.1. GlaxoSmithKline plc

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Pfizer Inc.

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Sanofi S.A.

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. Merck & Co., Inc.

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Indian Immunologicals Limited

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Pediatric Vaccines Market

27. Pediatric Vaccines Market Trends And Strategies

28. Pediatric Vaccines Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

Research Methodology

Why Buy From Us?

Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository

150+ Consulting project a year

100+ Analysts

8000+ Client Queries in 2022